Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 329
Infectious Diseases Drugs 239
Vaccines 239
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 173
Immune Disorders Drugs 155
Animal Pharmaceuticals 134
Central Nervous System Drugs 133
Women's Health 130
Cardiovascular Drugs 126
Pharmaceuticals 114
Musculoskeletal Disorders Drugs 101
Drug Discovery 96
Biopharmaceuticals 94
Respiratory Drugs 81
Oncology 73
Allergy and Immunology 71
Clinical Trials 70
Sexual and Reproductive Health Drugs 70
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 65
Antibiotics 62
Gastrointestinal Drugs 61
Biotechnology 60
Drug Delivery 59
Enzymes 57
Genomics 48
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 38
Infusions and Injectables 36
Diagnostics 35
Pulmonary Medicine 34
Lymphoma Drugs 34
Cancer Vaccines 33
Pharmaceutical Intermediates 32
Biosimilars and Biosuperiors 32
Hematological Drugs 31
Lung Cancer Drugs 30
Optical 28
HIV/AIDS Drugs 28
Urological Disorders Drugs 28
Pharmaceutical Manufacturing 28
Liver Cancer Drugs 26
Healthcare Services 25
Over the Counter (OTC) Drugs 25
Neurology 24
Immunosuppressive Drugs 24
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Vitamins and Dietary Supplements 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
E-Healthcare 15
Medical Devices 15
Biomarkers 15
Bladder Cancer Drugs 14
Gastroenterology 14
Hematology 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Alzheimer's Disease Drugs 13
Fertility Services 12
Ovarian Cancer Drugs 12
Nanomedicine 12
Therapeutic Area 11
Urology and Nephrology 11
Generic Drugs 11
Transdermal and Transmucosal Drug Delivery 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Uterine Cancer Drugs 7
Endocrinology 7
Bronchitis Drugs 7
Hepatology 6
Proteomics 6
Healthcare 6
Other Healthcare Facilities 6
Needles and Syringes 5
Laboratory Equipment 5
Company Reports 4
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

3,366 Results (Page 32 of 169)
- Relevance
  Sort by

Pain Management in Livestock Market - Global Forecast 2026-2032

 Report
September 2026
190 Pages
Global

From

€3313EUR$3,545USD£2,767GBP

€3681EUR$3,939USD£3,075GBP

Biopharmaceuticals - A Global Market Overview

 Report
February 2025
225 Pages
Global

From

€4205EUR$4,500USD£3,513GBP

Uveal Melanoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1869EUR$2,000USD£1,561GBP

Pet Allergy Treatment Market Insights, Competitive Landscape, and Market Forecast - 2033

 Report
March 2026
199 Pages
Global

From

€4667EUR$4,995USD£3,899GBP

Active Pharmaceutical Ingredients (API) Market by Type (Innovative, Generic), Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive Landscape - Global Forecast to 2030

 Report
October 2025
578 Pages
Global

From

€4625EUR$4,950USD£3,864GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Over-the-Counter Pain Medication - Global Strategic Business Report 2026

 Report
November 2026
483 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Contraceptive Pills Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
112 Pages
Global

From

€4438EUR$4,750USD£3,708GBP

H1N1 Vaccines - Global Strategic Business Report 2026

 Report
November 2026
325 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Preventable Vaccines - Global Strategic Business Report 2026

 Report
November 2026
391 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Tetanus Toxoid Vaccine - Global Strategic Business Report 2026

 Report
November 2026
265 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Psoriatic Arthritis Treatment - Global Strategic Business Report

 Report
November 2026
452 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Gout Disease Treatment - Global Strategic Business Report

 Report
November 2026
473 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Inactivated Polio and Rabies Vaccines - Global Strategic Business Report

 Report
November 2026
470 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Inactivated Vaccines - Global Strategic Business Report

 Report
November 2026
468 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Ebola Virus Vaccines - Global Strategic Business Report

 Report
November 2026
336 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Oral Typhoid Vaccines - Global Strategic Business Report

 Report
November 2026
183 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

DNA Vaccines - Global Strategic Business Report 2026

 Report
November 2026
171 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Bacterial Vaccines - Global Strategic Business Report

 Report
November 2026
490 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Adult Vaccines - Global Strategic Business Report

 Report
November 2026
377 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

Adenovirus Vaccines - Global Strategic Business Report

 Report
November 2026
279 Pages
Global

From

€5466EUR$5,850USD£4,566GBP

3,366 Results (Page 32 of 169)
- 1
- 30
- 31
- 32
- 33
- 34

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.